Cardiovascular safety of oral hormone replacement: Interim results from the EURAS-HRT study

被引：0

作者：

Dinger, Juergen ^{[1
]}

Assmann, Anita ^{[1
]}

Kolbeck, Ruediger ^{[1
]}

机构：

[1] ZEG Berlin Ctr Epidemiol & Hlth Res, Berlin, Germany

来源：

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2008年 / 17卷

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

617

引用

页码：S270 / S270

页数：1

共 50 条

[31] ASSESSING PRODUCT SAFETY VIA PATIENT BASED ACTIVE SURVEILLANCE (AS): A STUDY IN 30.000 WOMEN USING HORMONE REPLACEMENT THERAPY (HRT)
Heinemann, K.
Bardenheuer, K.
Potthoff, P.
VALUE IN HEALTH, 2013, 16 (07) : A331 - A331
[32] A randomised pilot study of hormone replacement therapy (HRT) in breast cancer patients: the combined effects of tamoxifen and HRT on the endometrium
Whitehead, M
EUROPEAN JOURNAL OF CANCER, 1998, 34 : S55 - S55
[33] Persistence with oral and transdermal hormone replacement therapy and hospitalisation for cardiovascular outcomes
Corrao, Giovanni
Zarnbon, Antonella
Nicotra, Federica
Fornari, Carla
La Vecchia, Carlo
Mezzanzanica, Mario
Nappi, Rossella E.
Merlino, Luca
Cesana, Giancarlo
MATURITAS, 2007, 57 (03) : 315 - 324
[34] Average Serum Estradiol Levels In Women Switching From Pharmaceutical Hormone Replacement Therapy (HRT) to Bioidentical HRT (BHRT)
Martin, James S.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (12): : 1382 - 1382
[35] Hormone replacement therapy (HRT) induces activation of coagulation - Results from a randomized, double-blind, clinical trial.
Hoibraaten, E
Qvigstad, E
Andersen, TO
Mowinckel, MC
Sandset, PM
BLOOD, 2000, 96 (11) : 269A - 269A
[36] Cardiovascular Safety in Users of Different Combined Oral Contraceptives - Final Results from the INAS-SCORE Study
Heinemann, Klaas
Dinger, Juergen
Thai Do Minh
Moehner, Sabine
Franke, Christian
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 48 - 48
[37] Safety and Performance of DBS Primary Cell IPG Replacement: An Interim Report from the ADROIT Study
Groppa, S.
Munoz, J.
Ashkan, K.
Gharabaghi, A.
Tomlinson, T.
Frassica, M.
Garcia, M. Navas
MOVEMENT DISORDERS, 2023, 38 : S858 - S858
[38] Cardiovascular disease risk and hormone replacement therapy (HRT): A review based on randomised, controlled studies in postmenopausal women
van Baal, WM
Kooistra, T
Stehouwer, CDA
CURRENT MEDICINAL CHEMISTRY, 2000, 7 (05) : 499 - 517
[39] Hormone replacement therapy and cardiovascular risk: consistency of results and unreliable data
Rosano, GMC
Fini, M
MATURITAS, 2001, 38 (03) : 225 - 226
[40] Safety of TTFields and radiotherapy (RT) for newly diagnosed glioblastoma: Interim safety results from a pilot study
Grossman, Rachel
Ram, Zvi
CANCER RESEARCH, 2018, 78 (13)

← 1 2 3 4 5 →